130 related articles for article (PubMed ID: 32833546)
1. Distribution Characteristics of Colorectal Peritoneal Carcinomatosis Based on the Positron Emission Tomography/Peritoneal Cancer Index.
Sun CF; Tan ZH; Shen C; Mao XY; Ge CC; Gao Y; Hu CH
Cancer Biother Radiopharm; 2022 Sep; 37(7):517-526. PubMed ID: 32833546
[No Abstract] [Full Text] [Related]
2. Application of Imaging Indicators Based on
Sun CF; Zhang D; Gao Y; Mao XY; Tan ZH; Bao SL; Shen C
Front Oncol; 2022; 12():888680. PubMed ID: 35720004
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
Liberale G; Lecocq C; Garcia C; Muylle K; Covas A; Deleporte A; Hendlisz A; Bouazza F; El Nakadi I; Flamen P
Anticancer Res; 2017 Feb; 37(2):929-934. PubMed ID: 28179354
[TBL] [Abstract][Full Text] [Related]
4. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
[TBL] [Abstract][Full Text] [Related]
5. Can [
Elekonawo FMK; Starremans B; Laurens ST; Bremers AJA; de Wilt JHW; Heijmen L; de Geus-Oei LF
Abdom Radiol (NY); 2020 Feb; 45(2):301-306. PubMed ID: 31642963
[TBL] [Abstract][Full Text] [Related]
6. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis.
Suzuki A; Kawano T; Takahashi N; Lee J; Nakagami Y; Miyagi E; Hirahara F; Togo S; Shimada H; Inoue T
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1413-20. PubMed ID: 15205922
[TBL] [Abstract][Full Text] [Related]
7. (18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study.
Cistaro A; Cucinotta M; Cassalia L; Priola A; Priola S; Pappalardo M; Coppolino P; De Simone M; Quartuccio N
Rev Esp Med Nucl Imagen Mol; 2016; 35(4):232-7. PubMed ID: 26907833
[TBL] [Abstract][Full Text] [Related]
8. Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin.
De Vos N; Goethals I; Ceelen W
Acta Chir Belg; 2014; 114(6):370-5. PubMed ID: 26021680
[TBL] [Abstract][Full Text] [Related]
9. Role of [
Zhao L; Pang Y; Luo Z; Fu K; Yang T; Zhao L; Sun L; Wu H; Lin Q; Chen H
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1944-1955. PubMed ID: 33415432
[TBL] [Abstract][Full Text] [Related]
10. Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.
Hotta M; Minamimoto R; Gohda Y; Igari T; Yano H
Eur Radiol; 2019 Oct; 29(10):5709-5716. PubMed ID: 30874878
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography.
Kim JH; Heo SH; Kim JW; Shin SS; Min JJ; Kwon SY; Jeong YY; Kang HK
World J Gastroenterol; 2017 Sep; 23(35):6448-6456. PubMed ID: 29085194
[TBL] [Abstract][Full Text] [Related]
12. PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum.
Wang SB; Ji YH; Wu HB; Wang QS; Zhou WL; Lv L; Shou T; Hu J
Medicine (Baltimore); 2017 Jan; 96(2):e5867. PubMed ID: 28079823
[TBL] [Abstract][Full Text] [Related]
13. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
[TBL] [Abstract][Full Text] [Related]
14. Preoperative CT-based predictive factors for resectability and medium-term overall survival in patients with peritoneal carcinomatosis from colorectal cancer.
Suzuki C; Wallgren H; Abraham-Nordling M; Palmer G
Clin Radiol; 2018 Aug; 73(8):756.e11-756.e16. PubMed ID: 29678273
[TBL] [Abstract][Full Text] [Related]
15. Validation of
Jónsdóttir B; Ripoll MA; Bergman A; Silins I; Poromaa IS; Ahlström H; Stålberg K
Cancer Imaging; 2021 Apr; 21(1):34. PubMed ID: 33849649
[TBL] [Abstract][Full Text] [Related]
16. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases.
Dresen RC; De Vuysere S; De Keyzer F; Van Cutsem E; Prenen H; Vanslembrouck R; De Hertogh G; Wolthuis A; D'Hoore A; Vandecaveye V
Cancer Imaging; 2019 Jan; 19(1):1. PubMed ID: 30616608
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.
Funicelli L; Travaini LL; Landoni F; Trifirò G; Bonello L; Bellomi M
Abdom Imaging; 2010 Dec; 35(6):701-7. PubMed ID: 19784697
[TBL] [Abstract][Full Text] [Related]
18. [Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125].
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Stabile Ianora AA; Giganti M; Niccoli Asabella A
Recenti Prog Med; 2012 Nov; 103(11):510-4. PubMed ID: 23096741
[TBL] [Abstract][Full Text] [Related]
19. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of FDG-positron emission tomography in diagnosing peritoneal recurrence of colorectal cancer.
Tanaka T; Kawai Y; Kanai M; Taki Y; Nakamoto Y; Takabayashi A
Am J Surg; 2002 Nov; 184(5):433-6. PubMed ID: 12433608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]